Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_775_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
46 Мб
Скачать
Ultrasound-Guided Anatomic Resection oftheLiver
JunichiShindoh, KiyoshiHasegawa, andMasatoshiMakuuchi
30
Abstract
Anatomic resection of the liver is an important concept to secure the local tumor control for hepatocellular carci­noma (HCC). For patients with primary, solitary HCC, systematic removal of the third-order tumor-bearing por­tal territories has been shown to be associated with longer time-to-recurrence after surgery and potentially longer overall survival. Although further clinical studies are needed to establish an optimal surgical strategy in man­agement of patients with HCC, anatomic resection of the liver has several clinical advantages, and hepatobiliary surgeons should be familiar with this technique. In this chapter, technical details and clinical advantages of ultrasound- guided anatomic resection of the liver were reviewed.

30.1 Introduction

Liver resection is the rst-line treatment in selected patients with primary or metastatic liver tumors. The safety of liver resection has dramatically improved over the decades with renements of perioperative management and surgical tech­niques. However, the most important factors inuencing on the surgical outcomes are surgeon’s knowledge on anatomy and basic principles pertaining to the surgical procedure.
For patients with hepatocellular carcinoma (HCC), sys-
tematic removal of the tumor-bearing portal territories, so
J. Shindoh (*) Hepatobiliary-pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan e-mail: shindou-tky@umin.ac.jp
K. Hasegawa Hepatobiliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
M. Makuuchi Koto Hospital, Tokyo, Japan
called “anatomic resection”, was proposed in 1980s as a theoretically optimal surgical procedure to expect eradica­tion of potential micrometastases surrounding tumors [1]. To date, a number of studies have reported that anatomic resec­tion may prolong the time-to-recurrence after surgery and potentially improve the overall survival [211], with clear evidence of a decrease in the local recurrence rate [6, 8, 10]. A latest study using a Markov model has further claried that complete removal of the tumor-bearing portal territory at ini­tial hepatectomy delays both recurrence and post-operative stage progression of HCC, yielding improved survival of patients with solitary HCC [11]. Although the optimal choice of surgical procedure for patients with HCC remains under debate, given these encouraging clinical outcomes, hepatobi­liary surgeons should be familiar with anatomic resection of the liver as a potentially appropriate surgical procedure in selected cases. In this chapter, we review the basic principles and techniques of ultrasound-guided anatomic resection of the liver.
30.2 Anatomical Principles andDenition
ofAnatomic Resection oftheLiver
Anatomic resection of the liver usually refers to “systematic removal of various combinations of the third-order portal ter­ritories”. According to the Brisbane 2000 terminology of liver anatomy and resections [12], resection of the rst-order portal territory is called hemihepatectomy and resection of the second-order portal area is dened as sectorectomy or sectionectomy. Couinaud’s segment is dened as the third­order division of the liver and monosegmentectomy is classi­ed as anatomic resection. However, Couinaud’s segment does not always correspond to the third-order portal territory because segment 2 is classied as the second-order portal territory, segment 5 or 8 usually consists of two or three third-order portal territories, and the denition of the caudate lobe (i.e., segment 1) is much more complex. The basic prin­ciples are that complete removal of any combination of third-
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022 M. Makuuchi et al. (eds.), The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases,
https://doi.org/10.1007/978-981-19-0063-1_30
241
242
Uncontrollable
2/3 hepatectomy)
1/3 hepatectomy)
J. Shindoh et al.
order portal territories can be classied as anatomic resection of the liver. Given that segment 5 and 8 usually have two or more third-order branches including ventral and dorsal branches [13], ventral/dorsal part of segment 5 or 8, ventral/ dorsal part of the right paramedian sector, or even more com­plex combination of portal territories [14] can be classied as anatomic resection of the liver as long as systematic removal of the corresponding portal territories is secured.

30.3 Surgical Indication

For liver resection of HCC, strict assessment of hepatic func­tional reserve is needed because HCC usually develops in an injured liver, and the maximum extent of hepatectomy in patients with chronic hepatitis or cirrhosis is limited to avoid postoperative hepatic insufciency, compared to those who have healthy livers. Liver resection is indicated only for Child-Pugh class A or B patients with controllable ascites and serum total bilirubin level of <2.0 mg/dL. Maximum extent of resection can be determined based on the measure­ment of indocyanine green retention rate at 15 min (ICG­R15) as proposed by Makuuchi etal. [4]. In original criteria for the maximum extent of resection, up to 2/3 hepatectomy (right hepatectomy or trisectionectomy) is accepted for patients with ICG-R15<10%, up to 1/3 hepatectomy (left hepatectomy or sectorectomy) is indicated for those with ICG-R15 between 10% and 19%, up to 1/6 hepatectomy (monosegmentectomy) is tolerated in those with ICG-R15
between 20% and 29%, and only limited partial hepatectomy or enucleation is indicated for patients with ICG-R15 equal to or greater than 30% (Fig. 30.1). Following strictly this algorithm, no operative mortality due to liver failure was recorded in 1056 consecutive patients at the University of Tokyo Hospital [15]. More recently, our group has adopted more sophisticated criteria based on the estimated ICG dis­appearing rate and precise three-dimensional volumetry of future liver remnant and it has been reported that the conven­tional criteria can be expanded safely, avoiding increased risk of postoperative hepatic insufciency [16, 17].

30.4 Surgical Technique

30.4.1 Exposure

Incision and exposure are key components of the quality of the exploration of the liver and the safety of hepatectomy. Different incisions, including the inverted L incision, the inverted-T inci­sion, the bilateral subcostal (chevron) incision, or the right/left subcostal incisions are used as well as the midline incision to achieve these objectives. Thoracotomy is sometimes required for safe exposure and manipulation of paracaval part of the liver. Meanwhile, recent laparoscopic technique has enabled us to minimize total length of incision through completing mobi­lization of the liver before opening the abdominal cavity, even in major hepatectomy which is not suitable for pure laparo­scopic approach (i.e., laparoscopic- assisted hepatectomy).
Ascites
None or controllable
Total bilirubin
<
1,0 mg/dL
=
ICG-R15
<10% 10-19% 20-29% 30-39% 40%–
Right hepatectomy
Trisectionectomy
(up to approx.
Fig. 30.1 Surgical indication criteria (Makuuchi Criteria) for patients with injured liver
Inoperable
1.1-1.5 mg/dL 1.6-1.9 mg/dL >2.0 mg/dL
Limited resection EnucleationInoperable
Left hepatectomy
Sectorectomy
(up to approx.
Segmentectomy
(up to approx.
1/6 hepatectomy)
Limited resection Enucleation
30 Ultrasound-Guided Anatomic Resection oftheLiver
243
30.4.2 Exploration andIntraoperative Ultrasound
After sufcient exposure of the liver, size, depth, location of tumors, their correlation to the surrounding vascular structures, presence/absence of new lesions, and intrahepatic blood ows are checked by ultrasound with or without contrast enhance­ment. Final surgical plans were then determined according to the preoperative data and intraoperative ndings.
30.4.3 Identication ofSegmental Border ontheLiver Surface
To conrm the segmental border to be transected, positive or negative staining is then performed. Positive staining (i.e., direct staining of the corresponding portal area) is conven-
a
tionally performed by injecting a blue dye (indigocarmine, Daiichi Sankyo Co., Ltd. Tokyo, Japan) into portal branches under ultrasound guidance. Tip of the needle is clearly visu­alized and injected dye can be conrmed as bubbles on ultra­sound images. To obtain clear staining, hepatic arteries are needed to be clamped at the hepatic hilum while staining portal branches to delay washout of injected dye. Also, injec­tion point and speed should be adjusted not to stain adjacent portal territories by regurgitation of the dye (Fig. 30.2a). When a tumor is located at the segmental border, corre­sponding tumor bearing portal branches should be stained respectively (Fig. 30.2b). However, when it is difcult to stain all the portal branches due to presence of multiple branches (e.g., segment 5) or too small size of branches which are difcult to be punctured (e.g., segment 1), nega­tive staining can be used as an alternative method to conrm the segmental border by staining adjacent portal territories.
b
c
Fig. 30.2 Technical details of anatomic resection of the liver (adapted
from Shindoh J, etal. J Hepatol 2016;64(3):594–600 with permission). (a) Segmental staining under ultrasound guidance. Tip of the needle and injected dye can be conrmed by ultrasound. (b) Staining of contiguous tumor-bearing third-order portal branches. When a tumor is located at the segmental border, corresponding tumor bearing portal branches should be stained respectively. (c) Anatomic resection of tumor-bearing segment. Anatomic resection can be achieved by (i) parenchymal tran-
section from the marked segmental border on the liver surface to the land mark veins, (ii) full exposure of the veins on the cut surface of the liver, and (iii) ligation of portal pedicles near the root of the segment. T tumor, P5 segment V portal branch, P8vent ventral branch of segment VIII portal branch, P8dor dorsal branch of segment VIII portal branch, P4sup superior branch of segment IV portal branch, LHV left hepatic vein, MHV middle hepatic vein, UFV umbilical ssure vein, V8i inter­mediate vein for segment VIII, IVC inferior vena cava
244
J. Shindoh et al.
For sectorectomy/sectionectomy or anatomic resection of left side of the liver, however, portal staining is not always necessary because direct ligation or transient clamp of the corresponding Glissonean pedicle is feasible extrahepati­cally to visualize demarcation line on the liver surface.
Although these staining methods are relatively easy and can be applicable in most of the cases in actual clinical set­tings, it is sometimes difcult to obtain a clear staining on liver surface especially in patients with severe cirrhosis or those undergoing repeat hepatectomy requiring extensive lysis of adhesions. For such instances, diluted ICG solution can be used as an alternative material for injection when uorescent imaging technique can be used [18].

30.4.4 Parenchymal Transection

Parenchymal transection is started along the segmental bor­der conrmed on the liver surface. To secure complete removal of the target part of the liver, the landmark veins are exposed on the cut surface of the liver and the corresponding
portal branches are ligated at the root of the segment (Fig. 30.2c). Because the intersegmental planes are not always at [19], it is important to carry out parenchymal transection under ultrasound guidance (i) from liver surface to the landmark veins and (ii) from the exposed landmark veins to the root of the corresponding portal pedicles. Figure 30.3 demonstrates a typical preoperative evaluation and intraoperative ndings of anatomic resection of dorsal part of segment 8.
30.4.5 Hemostasis andCheck forBile Leak
Injury of landmark veins during parenchymal transection can be secured by suture or application of brin glue accord­ing to the size of injury. Bile leak test [20] should be per­formed when cholecystectomy is carried out as a part of procedure because the shape of cut surface is relatively complex after anatomic resection of the liver and there is an increased risk of uid collection compared to those after simple partial hepatectomy.
a b
c d
Fig. 30.3 Example of anatomic resection of dorsal part of segment 8
(Adopted from Takamoto T etal. Am J Surg 2013;206(4):530–538 with permission). Anatomic resection of dorsal part of segment 8 is planned (a) and corresponding portal branch was punctured under ultrasound
guidance (b). Stained area visualized on liver surface (d) is very similar to the preoperative simulation (c). Based on the preoperative three­dimensional simulation (e), landmark veins (i.e., right hepatic vein and its tributary) are exposed on the cut surface of the liver (f)
e
30 Ultrasound-Guided Anatomic Resection oftheLiver
Fig. 30.3 (continued)
245
f

30.5 Clinical Advantages

solitary HCC and it remains inconclusive whether or not the same scenario can be applied for recurrent lesions, multiple

30.5.1 Technical Advantages

HCCs, or large HCC occupying two or greater Couinaud’s segments, the reported results suggest that initial selection of
From the practical standpoint, anatomic resection has several technical advantages. First, because the intersegmental plane at the watershed of portal territories are usually “avascular” excluding landmark veins, the risk of bile leak and amount of blood loss per area of the transection plane may be decreased
surgical procedure may have signicant inuence on subse­quent clinical course and survival outcomes of patients with HCC.Therefore, anatomic resection should be considered as a choice of surgical maneuver at initial hepatectomy for patients with solitary HCC.
[7]. Second, postoperative sustained hepatic dysfunction or disturbance of hepatic regeneration [13, 21, 22] could be avoided because no ischemic area or congested areas is pres-

30.6 Conclusions

ent after complete removal of a portal territory leaving inter­segmental venous branches at the cut surface of the liver. Third, branch-based volumetry or meticulous surgical plan­ning is feasible and the option of curative surgery can be proposed based on the objective volumetric data even for patients with a marginal hepatic functional reserve [2325].
Technical details and clinical advantages of anatomic resec­tion of the liver for patients with HCC were reviewed in this chapter. Although further clinical studies are needed to establish an optimal surgical strategy in management of patients with HCC, successful anatomic resection of tumor­bearing portal territory is reportedly delays long-term stage progression of HCC and may prolong survival outcomes.

30.5.2 Prognostic Advantages

Given that ultrasound-guided anatomic resection of the liver consists of various basic techniques required for more com-
Potential prognostic advantage of anatomic resection of the liver for primary, solitary HCC has been reported in many studies [210]. The University of Tokyo group previously
plex liver surgery, hepatobiliary surgeons need to be familiar with this procedure in the era of aggressive surgical manage­ment of advanced hepatobiliary malignancies.
reported that complete removal of tumor-bearing portal ter­ritories decreases the risk of local recurrence and death from HCC based on a database established under strict quality control [7] and recent large multi-institutional cohort studies have yielded similar outcomes [2, 9]. Another recent study conducted at a Japanese high-volume center has further clar­ied the differences in time-to-interventional failure and transition rate from the early recurrence stage to advanced stages according to the choice of surgical maneuver at initial hepatectomy for solitary HCC [11]. Although these results were conrmed only in a specic population with primary,

References

1. Makuuchi M, Hasegawa H, Yamazaki S.Ultrasonically guided sub­segmentectomy. Surg Gynecol Obstet. 1985;161(4):346–50.
2. Kaibori M, Kon M, Kitawaki T, Kawaura T, Hasegawa K, Kokudo N, etal. Comparison of anatomic and non-anatomic hepatic resec­tion for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2017;24(11):616–26.
3. Kakazu T, Makuuchi M, Kawasaki S, Miyagawa S, Hashikura Y, Kosuge T, et al. Repeat hepatic resection for recurrent hepatocel­lular carcinoma. Hepato-Gastroenterology. 1993;40(4):337–41.
246
J. Shindoh et al.
4. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9(4):298–304.
5. Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J.Extent of liver resection inuences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery. 2002;131(3):311–7.
6. Shindoh J, Hasegawa K, Inoue Y, Ishizawa T, Nagata R, Aoki T, etal. Risk factors of post-operative recurrence and adequate sur­gical approach to improve long-term outcomes of hepatocellular carcinoma. HPB (Oxford). 2013;15(1):31–9.
7. Shindoh J, Makuuchi M, Matsuyama Y, Mise Y, Arita J, Sakamoto Y, et al. Complete removal of the tumor-bearing portal territory decreases local tumor recurrence and improves disease-specic survival of patients with hepatocellular carcinoma. J Hepatol. 2016;64(3):594–600.
8. Tanaka S, Mogushi K, Yasen M, Noguchi N, Kudo A, Kurokawa T, et al. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma. J Am Coll Surg. 2009;208(3):368–74.
9. Vigano L, Procopio F, Mimmo A, Donadon M, Terrone A, Cimino M, et al. Oncologic superiority of anatomic resection of hepato­cellular carcinoma by ultrasound-guided compression of the por­tal tributaries compared with nonanatomic resection: an analysis of patients matched for tumor characteristics and liver function. Surgery. 2018;164(5):1006–13.
10. Wakai T, Shirai Y, Sakata J, Kaneko K, Cruz PV, Akazawa K, etal. Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol. 2007;14(4):1356–65.
11. Shindoh J, Kobayashi Y, Umino R, Kojima K, Okubo S, Hashimoto M.Successful anatomic resection of tumor-bearing portal territory delays long-term stage progression of hepatocellular carcinoma. Ann Surg Oncol. 2021;28(2):844–53.
12. Terminology Committee of the International Hepato-Pancreato­Biliary Association. The Brisbane 2000 terminology of liver anat­omy and resections. HPB (Oxford). 2000;2(3):333–9.
13. Shindoh J, Satou S, Aoki T, Beck Y, Hasegawa K, Sugawara Y, et al. Hidden symmetry in asymmetric morphology: signi­cance of Hjortsjo’s anatomical model in liver surgery. Hepato­Gastroenterology. 2012;59(114):519–25.
14. Shindoh J, Nishioka Y, Hashimoto M. Bilateral anatomic resec­tion of the ventral parts of the paramedian sectors of the liver with total caudate lobectomy for deeply/centrally located liver tumors: a new technique maximizing both oncological and surgical safety. J Hepatobiliary Pancreat Sci. 2017;24(12):E10–6.
15. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, etal. One thousand fty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138(11):1198–206. discussion 206
16. Kobayashi Y, Kiya Y, Nishioka Y, Hashimoto M, Shindoh J. Indocyanine green clearance of remnant liver (ICG-Krem) predicts postoperative subclinical hepatic insufciency after resection of colorectal liver metastasis: theoretical valida­tion for safe expansion of Makuuchi's criteria. HPB (Oxford). 2020;22(2):258–64.
17. Kobayashi Y, Kiya Y, Sugawara T, Nishioka Y, Hashimoto M, Shindoh J. Expanded Makuuchi’s criteria using estimated indo­cyanine green clearance rate of future liver remnant as a safety limit for maximum extent of liver resection. HPB (Oxford). 2019;21(8):990–7.
18. Kobayashi Y, Kawaguchi Y, Kobayashi K, Mori K, Arita J, Sakamoto Y, etal. Portal vein territory identication using indocya­nine green uorescence imaging: technical details and short-term outcomes. J Surg Oncol. 2017;116(7):921–31.
19. Shindoh J, Mise Y, Satou S, Sugawara Y, Kokudo N.The interseg­mental plane of the liver is not always at--tricks for anatomical liver resection. Ann Surg. 2010;251(5):917–22.
20. Zimmitti G, Vauthey JN, Shindoh J, Tzeng CW, Roses RE, Ribero D, etal. Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg. 2013;217(6):1028–37.
21. Sano K, Makuuchi M, Miki K, Maema A, Sugawara Y, Imamura H, et al. Evaluation of hepatic venous congestion: proposed indication criteria for hepatic vein reconstruction. Ann Surg. 2002;236(2):241–7.
22. Maema A, Imamura H, Takayama T, Sano K, Hui AM, Sugawara Y, et al. Impaired volume regeneration of split livers with partial venous disruption: a latent problem in partial liver transplantation. Transplantation. 2002;73(5):765–9.
23. Mise Y, Hasegawa K, Satou S, Aoki T, Beck Y, Sugawara Y, et al. Venous reconstruction based on virtual liver resection to avoid con­gestion in the liver remnant. Br J Surg. 2011;98(12):1742–51.
24. Saito S, Yamanaka J, Miura K, Nakao N, Nagao T, Sugimoto T, etal. A novel 3D hepatectomy simulation based on liver circula­tion: application to liver resection and transplantation. Hepatology. 2005;41(6):1297–304.
25. Takamoto T, Hashimoto T, Ogata S, Inoue K, Maruyama Y, Miyazaki A, etal. Planning of anatomical liver segmentectomy and subsegmentectomy with 3-dimensional simulation software. Am J Surg. 2013;206(4):530–8.
Parenchyma-sparing Hepatic Resection forMultiple Metastatic Tumors
BrunoBranciforte, FlavioMilana, andGuidoTorzilli
31
Abstract
Liver surgery is actually asked to deal with high tumor burden also in case of colorectal metastases. Harming the most diseased part to hypertrophy the future liver remnant remains the mainstream. However, ultrasound guidance has progressively driven to challenge the tumor-vessel detachment (R1vasc), which has proven to be oncologi­cally suitable in term of local control. This nding has boosted the suitability of parenchyma sparing surgery even when tumor burden is extremely high. A further improvement in this sense has been provided in case of hepatic vein tumoral stricture or occlusion: indeed, in these circumstances natural by-pass develop preserving the outow. Through ultrasound and vessel guidance, parenchyma sparing surgery has entered the complexity. From there, a different way of large tissue deprivation: the meaningful parenchymal sparing major hepatectomies.

31.1 Introduction

Surgical resection is the only potentially curative treatment for metastatic tumors in the liver. Patients with colorectal liver metastases (CLMs) are often addressed to multiple hepatic resections, but initial experiences with major hepatic resection were associated with a high peri-operative mortal­ity. Preservation of an adequate remnant liver volume after resection became recognized as one of the most relevant
B. Branciforte · F. Milana Division of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center IRCCS, Milan, Italy
G. Torzilli ( Division of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center IRCCS, Milan, Italy
Department of Biomedical Sciences, Humanitas University, Milan, Italy e-mail: guido.torzilli@hunimed.eu
*)
issue in the prevention of post-hepatectomy liver failure (PHLF), and one of the main cause of post-operative mortality.
To maximize the safety of liver surgery, and expand the suitability of the surgical treatment, surgeons tended to develop operative techniques that limit the extent of paren­chymal resection, tailoring the resection to the extent of the pathology without compromising cancer-specic outcomes.
A better understanding of intrahepatic anatomy and tumor biology, as well as advances in imaging technologies, together with improvement in peri- and intraoperative man­agement, allowed expanding indications and performing more aggressive and complex procedures.
The parenchyma-sparing surgery (PSS) philosophy is a part of this perspective and merges the oncologic rules of surgery with minimal sacrice of liver tissue.

31.2 Multiple Bilobar CLM

Liver surgery represents the standard of treatment for CLMs, even in patients with multiple and/or bilobar lesions. These patients are the most complex to treat because a large paren­chyma sacrice is often needed. Moreover, in patients with underlying liver disease (or even in those who have received multiple cycles of chemotherapy), the risk of developing post hepatectomy liver failure (PHLF) is even higher [1].
Reducing the risk of PHLF whenever a major removal of functioning liver tissue was performed has been the main tar­get of many surgeons. In early 2000 Adam etal. proposed a staged procedure scheduling as rst step a debulking surgery, limiting the CLM clearance to one side of the organ, and in a second operation the denitive organ clearance: the so-called 2-stage hepatectomy (TSH) [2]. For improving the efciency of the approach Jaeck etal. introduced, in between the two step, a portal vein embolization of the right hemiliver for inducing hyperthrophy of the left [3]. The main disadvantage
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022 M. Makuuchi et al. (eds.), The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases,
https://doi.org/10.1007/978-981-19-0063-1_31
247
248
ef
bc
RHV
B. Branciforte et al.
a
LHV
d
UP
B
D
MHV
Fig. 31.1 (a) virtual liver cast based on CT images of a patient carrier
of 19 colorectal liver metastases (dark pink); the glissonean branches in light pink; hepatic veins in dark blue; inferior vena cava in light blue. (b, c) resection areas (yellow and orange dotted lines) drawn with elec­trocautery on the liver surface. (d–f) cut surfaces at the end of the tumor
of TSH is the non-negligible risk of drop-out: about one­third of patients do not receive the second hepatectomy because of disease progression between the 2 stages or inad­equate hypertrophy of the future liver remnant (FLR) [4]. More recently, the associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) has been proposed: despite, this approach, a sort of fast-track TSH, guarantees a signicantly lower drop-out rate compared to TSH, surgical risk and long-term oncological results remain open issues [57]. Finally, liver venous deprivation (LVD) followed by major hepatectomy is the last release aiming to empower liver regeneration. Simultaneous occlusion of portal vein inow and hepatic vein (HV) outow for harming part of the liver seems safe, and efcient in terms of FLR increase and consequent drastic limitation of patients’ drop-out [8, 9]. Anyhow, all these solutions boosting the FLR by means of major vessel amputation reduce the chance of redo surgery in case of relapses. Indeed, it seems somehow obvious that less remnant vascular structures offer lower freedom degrees for nding technical solutions able to clear the organ.
In the last decades, PSS has been increasingly adopted [10]. However, several authors have limited the application of their parenchyma-sparing policy to a “cherry-picking sur­gery” (limited peripheral resection) or anatomic segmentec­tomy [11]. In presence of supercial lesions, single-session multiple minor resections are commonly adopted, but in case of deep-located CLMs, staged hepatectomy still remains the
LHV
Gp2
Gp3
removals; the cut surfaces surrounded by the yellow and orange dotted lines refer to the previously highlighted resection areas. RHV, Right Hepatic Vein, MHV Middle Hepatic Vein, LHV Left Hepatic Vein, IVC Inferior vena cava, Gp glissonean pedicles (numbers refer to the seg­ment fed), UP umbilical portion
preferred option. The authors have extensively demonstrated the feasibility, safety and efcacy of IOUS-guided PSS for CLMs [1217].
In particular, the possibility to resect in a PSS perspective also deep lesions with complex intrahepatic relations have been explored, namely with the so-called enhanced one­stage hepatectomy (E-OSH) [14, 18] (Fig.31.1). Minimizing the parenchyma sacrice, and preserving the liver scaffold were the pillars of an approach devoted to be radical, and conservative. Increased safety and salvageability in case of relapse have been the merits of this policy. In particular, sal­vageability means better long-term disease control: recent series reported ve-year survival rates after surgery of about 50%, despite up to 70–80% of patients having disease recur­rence [19, 20].
Intra-operative ultrasound (IOUS) guidance, tumor vessel detachment and the presence of communicating veins (CVs) preserving liver outow whenever detachment is unfeasible, are the main technical pillars in which advanced PSS relies.

31.2.1 Intraoperative Ultrasound

IOUS, used in hepatic surgery since the early 1980s [21], has been repeatedly advocated as a useful tool for resection guid­ance both in primary and secondary metastatic tumors, and represents the cornerstone of PSS policy [12]. Despite several
31 Parenchyma-sparing Hepatic Resection forMultiple Metastatic Tumors
249
reasons may explain decrease in mortality following major hepatic resection reached in the last decades [22], a privileged role should be surely assigned to improved operative tech­niques which became feasible thanking to IOUS guidance.
Indeed, IOUS makes possible creating complex multiplanar dissection trajectories during liver resection, then really open­ing to policies alternative to major hepatectomies [23, 24].
The use of IOUS in liver resections could be divided into three main phases: (1) liver exploration for disease staging, (2) planning of the surgical strategy, and (3) surgical maneu­vers guidance. Although palpation still plays a fundamental phase, for deep located lesions IOUS exploration represents a crucial intraoperative tool, rened on the possibility of con­trast enhancement (CE-IOUS). Despite progress in preoper­ative imaging, adding CE-IOUS to IOUS exploration showed to modify the operative plan in up to 38% of patients with CLM, with its ability in recognizing new lesions otherwise not visible [25].
Moreover, IOUS allows an accurate estimation of the relationship among the tumor and vessels (both glissonian pedicles and HVs), which is a fundamental step in dening the most appropriate surgical strategy. Indeed, the tumor­vessel relationship represents a crucial point in parenchymal­sparing policy, being informative in discriminating a vascular contact from a vascular inltration.

31.2.2 Tumor-vessel Detachment

Surgeons have progressively moved from the 1-cm rule to the 1-mm rule, but negative surgical margin (R0) has been considered as the standard while R1 resection as an unfavor­able surgical result [26]. Nevertheless, vascular wall may represent a boundary to tumor spread, and vascular detach­ment could be performed safely. Specically, R1 vascular (R1vasc) resection is dened as any tumor detachment from rst/second-order glissonean pedicles (in contact with up to half of the pedicle circumference) or from HVs (in contact with up to two-thirds of the vein circumference) within their last 4cm before hepato-caval conuence [23]. R1vasc cor­responds to tumor exposure (0-mm margin) along the “detachment area” and it has been demonstrated offering equivalent results to R0 resection in terms of local recurrence and 5-year survival [17, 27]. R1vasc suitability is the crucial nding which could make reliable not just the PSS strategy but the tissue removal preserving the organ scaffold: this could mean resecting conservatively complex presentation otherwise affordable just with major hepatectomies or staged procedure or resulting even unresectable.
To maximize the feasibility of R1vasc resections, IOUS­based criteria have been introduced and validated [12, 13]:
the circumferential extent of the contact represents the main driver for deciding to spare or not the vessel.

31.2.3 Communicating Veins

in the event of clear vessel wall inltration, vascular resec­tion is mandatory. Liver resection for tumors involving the major HVs nearby the hepatocaval junction traditionally requires major anatomical resection with or without venous reconstruction. HVs, when inltrated, in the majority of situations could be anyhow spared by means of tangential resection with direct reconstruction or seldom patching [17]. In the event this would not be feasible, then in case of more signicant inltration, despite HVs are sacriced the drained area of liver parenchyma could be almost always spared. Indeed, in such conditions which mimics a Budd­Chiari Syndrome, CVs between major HVs, exist and can be identied in up to 80% of patients with a tumor at the hepatocaval conuence [28]. CVs represent an outow pathway alternative to major HVs, making suitable to pre­serve liver venous discharge even when a major HV is resected. This further possibility increases the suitability of conducting PSS.
Preoperative imaging ndings can suggest CV patency, by direct visualization or just conrming a uniform enhance­ment of the liver parenchyma at venous phase for CT or hepato-specic delayed phase for MRI.Anyhow, CV patency is denitively detected by IOUS color-ow analysis. Moreover, HV clamping during surgery may offer additional data: CV patency can be enhanced, and persistent hepatope­tal portal inow, even in the absence of evident CVs, is a permissive condition for PSS [13, 28]. Their presence guar­antees otherwise unfeasible technical solutions, thus leading ineligible patients undergoing radical surgery and avoiding major hepatectomies.

31.3 New Procedures

The IOUS indicates the door for entering into the liver, and the vessel guides the surgeon once inside. Following the intrahepatic vessels from the surface to the deep warrantees anyhow an anatomical approach, but with innite trajectories according to the selected vessel, then innite solutions. Parenchyma sparing vessel guided hepatectomies (PSVGH) for sculpturing the organ, implementing the portfolio of sur­gical options, and increasing the salvageability in case of relapse by keeping the major in and out-ow intrahepatic vascular structures [29]. Cornerstone of PSVGH are the fol­lowing new parenchymal-sparing procedures:
250
B. Branciforte et al.
31.3.1 Systematic Extended Right Posterior Sectionectomy (SERPS)
Right posterior sectionectomy (S6-7) extended to part of S5 and S8 with section of the right HV (RHV). The outow of spared S5 and/or S8 is provided by branches of the middle HV (MHV) (Fig.31.2).
[30]
31.3.1.1 Eligibility Criteria
Patients suitable for SERPS are those with tumors showing:
A. invasion of the RHV close to the hepato-caval conuence
(within 4 cm), with other lesions involving segment 6 and eventually segment 7 (Fig.31.2a).
B. invasion of the RHV close to the hepato-caval conu-
ence (within 4cm), without other lesions involving seg­ment 6, but without inferior RHV (IRHV), and with hepatofugal portal blood ow at color-ow IOUS in por­tal branch to segment 6 (P6) when RHV is clamped (Fig.31.2b).
C. contact with the right anterior glissonean sheat, and a
relation with the right posterior having at least one of the following features: contact with dilation of bile ducts of right posterior section, vessel wall invasion, or contact wider than one-third of pedicle circumference (Fig.31.2c).
31.3.2.1 Mini-Upper Transversal Hepatectomy
Anatomic or limited resection of S7-8 with section of the RHV. The outow of S5 and S6 is provided by an IRHV [31], by branches of the MHV [20] or by CVs between the RHV and/or left HV (LHV) and the MHV [32].
31.3.2.2 Right Upper Transversal Hepatectomy [33]
Anatomic or limited resection of S7-8-4s with section of the RHV and the MHV.The outow of S4i-5-6 is provided by the IRHV and/or CVs only, among the RHV, the MHV and the LHV.
31.3.2.3 Left Upper Transversal Hepatectomy [24]
Anatomic or limited resection of S2-4s or of S2-4s-8 with section of the LHV or the LHV and the MHV.The outow of segments 3-4i-5 is provided by CVs among the RHV, the MHV and the LHV.
31.3.2.4 Total Upper Transversal Hepatectomy [24, 34]
Anatomic or limited resection of S2-4s-7-8 with section of the RHV, the MHV and the LHV in presence of an IRHV and CVs among the liver-side stumps of the HVs, which warran­tee the outow of S3-4i-5-6.
Eligibility Criteria

31.3.2 Upper Trasversal Hepatectomy (UTH))

Tumor at caval conuence invading from one to all HVs at
caval conuence in presence of an IRHV, and CVs or just Transversal hepatectomies for tumors involving more than one and up to all the HVs at hepato-caval conuence. The following subtypes can be recognized:
RHV
ab c
T
Fig. 31.2 schemas of patterns eligible for Systematic Extended Right
Posterior Sectionectomy (SERPS); (a) tumor (T) invading the right hepatic vein (RHV) with others involving segment 6; (b) T invading the RHV with hepatofugal (white arrows) portal vein blood ow in glisso­nean pedicles for segments 6 (Gp6) and 7 (Gp7); (c) T in contact with
Gp7
Gp6
RHV
T
CVs. The tumor could lie over the hilar plate with contact but
no invasion of the right and left portal branches, and the seg-
mental portal branches to the antero-inferior segments.
the 2nd order right Gp, but with dilated bile duct draining segment 6
(dB6) and 7 (dB7) indicating the invasion of the Gp of the right poste-
rior section. Green arrow = dissection plane of the SERPS. Yellow
arrow=dissection plane of the right hepatectomy
RHV
dB7
T
dB6